ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,084.87
      0.28%
      US Tech 100
      17,095.55
      0.55%
      Dow Jones
      38,482.11
      -0.06%
      Brent Oil
      87.32
      -0.28%
      Bitcoin
      65,991.52
      -0.63%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Viridian Therapeutics Inc (VRDN)

      7. Viridian Therapeutics Inc (VRDN) News

      VRDN Viridian Therapeutics Inc

      14.25
      0.00 (0.00%)
      Pre Market
      Last Updated: 08:39:18
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Viridian Therapeutics Inc VRDN NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 14.25 08:39:18
      Open Price Low Price High Price Close Price Prev Close
      14.25
      more quote information »

      Recent News

      Date Time Source Heading
      4/04/202416:01BWViridian Therapeutics Announces Inducement Grants Under..
      3/06/202416:01BWViridian Therapeutics Announces Inducement Grants Under..
      3/05/202408:00BWViridian Therapeutics to Participate in the Leerink Partners..
      2/28/202416:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202416:07EDGAR2Form 8-K - Current report
      2/27/202416:01BWViridian Therapeutics Highlights Recent Progress and Reports..
      2/16/202408:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
      2/14/202420:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202416:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202416:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
      2/14/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202409:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/07/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/06/202416:01BWViridian Therapeutics Announces Inducement Grant Under..
      1/24/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202417:12EDGAR2Form SC 13D/A - General statement of acquisition of..
      1/19/202417:22EDGAR2Form 8-K - Current report
      1/19/202416:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/17/202422:00BWViridian Therapeutics Announces Pricing of Public Offering..
      1/17/202416:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/17/202416:01BWViridian Therapeutics Announces Proposed Underwritten Public..
      1/12/202416:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/08/202408:08EDGAR2Form 8-K - Current report
      1/08/202408:00BWViridian Therapeutics to Present Key 2024 Corporate..
      1/04/202408:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
      12/18/202311:45EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202308:15EDGAR2Form 8-K - Current report
      12/18/202307:00BWViridian Therapeutics Announces Positive Clinical Data in..
      12/12/202316:19EDGAR2Form 144 - Report of proposed sale of securities
      12/08/202316:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      12/07/202316:22EDGAR2Form 144 - Report of proposed sale of securities
      12/01/202316:04EDGAR2Form 144 - Report of proposed sale of securities
      11/30/202316:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
      11/21/202308:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
      11/13/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202316:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
      11/08/202308:00BWViridian Therapeutics to Participate in the Jefferies London..
      11/03/202316:30EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/03/202308:00BWViridian Therapeutics Announces Encore Presentations at the..
      11/01/202321:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
      11/01/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/01/202316:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
      10/30/202308:35EDGAR2Form 8-K - Current report
      10/30/202308:30BWViridian Therapeutics Appoints New Chief Executive Officer,..
      10/26/202308:00BWViridian Therapeutics Enters Autoinjector Pen Device..
      9/25/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      VRDN
      Viridian Therapeutics
      Delayed Upgrade Clock